Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Acute levodopa may worsen motor plasticity in late-stage PD

Administering acute doses of levodopa appears to worsen motor cortex plasticity as Parkinson’s disease advances, researchers report.

14 Jun 2012

Potential predictor of fast PD progression identified

The identification of genetic variants of the α-synuclein gene may help to predict which individuals with idiopathic Parkinson’s disease are likely to experience fast progression of motor symptoms, according to findings from a US-based genetic study.

14 Jun 2012

Targeting noradrenergic system combats gait freezing in Parkinson’s patients

Methylphenidate may be a useful treatment for patients with advanced Parkinson's disease receiving subthalamic nucleus stimulation who experience gait hypokinesia and freezing, show findings from a randomized trial.

14 Jun 2012

New analogues effective in inhibiting NOS activity in Parkinson models

University of Granada researchers have tested melatonin analogues in rats as it inhibits the enzyme nitric oxide synthase (NOS), which is involved in the development of conditions as inflammatory bowel disease, septic shock or rheumatoid arthritis, as well as in neurodegenerative conditions as Huntington's disease, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.

14 Jun 2012

New study on motor chunking

You pick up your cell phone and dial the new number of a friend. Ten numbers. One. Number. At. A. Time. Because you haven't actually typed the number before, your brain handles each button press separately, as a sequence of distinct movements.

13 Jun 2012

Changes in walking speed in late life may signal MCI

A new study shows that changes in walking speed in late life may signal the early stages of dementia known as mild cognitive impairment (MCI).

12 Jun 2012

Updated AAN guideline outlines treatments for infantile spasms

The American Academy of Neurology has issued an updated guideline outlining the best treatments for infantile spasms, a rare type of seizure that can occur in infants and young children.

12 Jun 2012

Mutation responsible for rare, hereditary motor neuron disease disrupts vital links

Studying how nerve cells send and receive messages, Johns Hopkins scientists have discovered new ways that genetic mutations can disrupt functions in neurons and lead to neurodegenerative disease, including amyotrophic lateral sclerosis (ALS).

11 Jun 2012

Researchers identify new mitochondrial protein complex linked with type 2 diabetes

Researchers at Metabolic Solutions Development Company, LLC (MSDC) have identified a mitochondrial protein complex through which anti-diabetic drugs exert their insulin sensitizing effects when used to treat patients diagnosed with type 2 diabetes.

11 Jun 2012

eHealth offers Europe solutions that can help avoid healthcare crisis

Healthcare systems face enormous challenges over the coming years. The increasing demands of an aging population, the rising cost of treatments and medications, and budget shortfalls are all issues that will need to be addressed if Europeans are to continue to enjoy high standards of care. eHealth, enabled by information and communication technologies, offers Europe solutions that can help avoid healthcare crisis.

8 Jun 2012

LBDA launches nationwide October awareness movement

Today the Lewy Body Dementia Association (LBDA) launched its nationwide October awareness movement, "A Month To Remember." LBDA invites volunteers to join the movement by "Standing Strong with LBDA" to build awareness for Lewy body dementia in their communities.

8 Jun 2012

DiaGenic initiates [18F] Flutemetamol PET imaging clinical study in MCI

DiaGenic ASA today announced that the first patient with MCI (Mild Cognitive Impairment) was examined with [18F] Flutemetamol PET imaging at University of Lund Sweden in the DiaGenic and GE Healthcare Research Collaboration announced March 27th 2012.

8 Jun 2012

Banyan, Amarantus complete collaboration agreement related to TBI development program

Amarantus BioSciences, Inc., a biotechnology company developing new treatments for brain-related disorders including traumatic brain injury (TBI) based on its proprietary anti-apoptotic therapeutic protein known as MANF and Banyan Biomarkers, the leader in developing in vitro diagnostic products to detect TBI, today announced the successful completion of a collaboration agreement initiated in November 2011 to evaluate MANF's potential as a disease-modifying agent for the treatment of TBI.

8 Jun 2012

Scientists discover new function for thrombospondin protein

Scientists have discovered a new function for a protein that protects cells during injury and could eventually translate into treatment for conditions ranging from cardiovascular disease to Alzheimer's.

8 Jun 2012

FDA approves XenoPort, GSK’s Horizant ER tablets for management of PHN

GlaxoSmithKline plc (GSK) and XenoPort, Inc. announced today that the United States (US) Food and Drug Administration (FDA) has approved Horizant (gabapentin enacarbil) Extended-Release Tablets for the management of postherpetic neuralgia (PHN) in adults.

7 Jun 2012

Plasma levels of tau appear to be a strong predictor for AD

A study by researchers at the Banner Sun Health Research Institute suggests that plasma levels of tau, a protein formed in the brain, appears to be a biomarker and a strong predictor for Alzheimer's disease.

7 Jun 2012

Patent claims for technology to assess Parkinson’s disease issued to Great Lakes Neurotechnologies

Great Lakes NeuroTechnologies announced today that the U.S. Patent Office has issued claims under patent number 8,187,209 covering their Movement Disorder Monitoring System and Method for quantitative assessment of motor symptoms associated with movement disorders.

6 Jun 2012

Soy protein may not enhance overall cognitive ability in women

Contrary to earlier reports, a new study suggests that soy protein may not preserve overall thinking abilities in women over the age of 45, but may improve memory related to facial recognition.

5 Jun 2012

Parkinson’s vaccine: worldwide first clinical trial begins

The worldwide first clinical trial for the development of a Parkinson´s vaccine has now been started by AFFiRiS AG.

5 Jun 2012

Researchers identify predictive biomarker for Parkinson's disease

Because there is currently no laboratory test that can diagnose Parkinson's disease, it is practically impossible to detect those individuals who are in the earliest stages of the disease. As a result, Parkinson's disease can only be diagnosed by a clinical neurological examination based on findings suggestive of the disease.

5 Jun 2012

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Acute levodopa may worsen motor plasticity in late-stage PD

Potential predictor of fast PD progression identified

Targeting noradrenergic system combats gait freezing in Parkinson’s patients

New analogues effective in inhibiting NOS activity in Parkinson models

New study on motor chunking

Changes in walking speed in late life may signal MCI

Updated AAN guideline outlines treatments for infantile spasms

Mutation responsible for rare, hereditary motor neuron disease disrupts vital links

Researchers identify new mitochondrial protein complex linked with type 2 diabetes

eHealth offers Europe solutions that can help avoid healthcare crisis

LBDA launches nationwide October awareness movement

DiaGenic initiates [18F] Flutemetamol PET imaging clinical study in MCI

Banyan, Amarantus complete collaboration agreement related to TBI development program

Scientists discover new function for thrombospondin protein

FDA approves XenoPort, GSK’s Horizant ER tablets for management of PHN

Plasma levels of tau appear to be a strong predictor for AD

Patent claims for technology to assess Parkinson’s disease issued to Great Lakes Neurotechnologies

Soy protein may not enhance overall cognitive ability in women

Parkinson’s vaccine: worldwide first clinical trial begins

Researchers identify predictive biomarker for Parkinson's disease

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in